fashion -WSS

fashion

author：hotspot 2025-09-28 00:50:23 - browse：426

A collage illustration with a patient in the center with a hand to the left administering treatment and a doctor in the background. -- health tech coverage from STAT — Katy Lemay for STAT

The makers of minimally invasive surgical devices seemed poised to capture a wide swath of the obesity treatment market. Patients needed an option that lay between the two treatment extremes: cutting open the abdomen to perform permanent bariatric surgery, or changing your diet or exercise routine.

Then, a new class of weight loss medications that successfully mimic the feeling of fullness hit the market, and the landscape changed.

“It turns out that what came along — before those endoscopic devices have really matured — is these new drugs,” said Lee Kaplan, director of Massachusetts General’s obesity institute. Since the Food and Drug Administration approved Novo Nordisk’s Wegovy in 2021, it and similar drugs that followed have swiftly captured the public’s interest — and are on their way to generating billions of dollars in sales.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Allen Institute goes after foundational questions, CEO Costa says

WSS

Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

Arena BioWorks launches in Cambridge to speed drug discovery

Ascension's ugly legal battle over care for poor patients in Texas

Medicare Advantage overpayments discussion gets experts fired up

Stories you might have missed in 2023: health, science, medicine

Typhoon Doksuri makes landfall in China after bringing deadly landslides to Philippines

entertainment

fashion

leisure time

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

American taxpayers paid $1.8 trillion in health care costs in 2022

Duchenne breakthrough therapy leaves behind pioneering families

STAT Virtual Event: JPM Recap, Live!

Alkermes shareholders re

Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

Cancer drug shortages should be causing more outrage

In shift, Texas to cover initial consult for Afghan baby's gene therapy

Bright Health sells Medicare Advantage business to Molina

JPM 2024: Biotech’s most prolific dealmaker sees a rosy 2024

focus

Doctors in states that ban abortion can still help patients

House GOP plan to stem drug shortages differs from Democrats’

Arena BioWorks launches in Cambridge to speed drug discovery

American taxpayers paid $1.8 trillion in health care costs in 2022

What AstraZeneca

Judge orders hearing on Trump's motion to disqualify Fulton County DA

Wikipedia

entertainment

Wikipedia

Wikipedia